论文部分内容阅读
目的评价慢性心力衰竭(CHF)住院患者药物治疗的现状。方法调查我院1998年1月～2008年12月住院的CHF病例资料,将其2002年度之前的分为A组,之后的分为B组,统计分析两组患者的一般临床情况、心功能分级、超声心动图指标、药物使用、住院时间及死亡等情况和指标。结果近10年间共收治CHF患者620例,其中A组178例,B组442例,两组患者的一般临床情况、心功能分级及超声心动图指标比较无统计学差异(p>0.05);B组患者血管紧张素转换酶抑制剂、β-受体阻滞剂和螺内酯的使用率明显高于A组,地高辛和利尿剂使用率略低于A组;A组患者平均住院天数显著长于B组,住院期间死亡率明显高于B组;统计学上有显著性差异(p<0.005)。结论慢性心力衰竭治疗建议显著提高了我院药物治疗心力衰竭的水平。
Objective To evaluate the medical treatment of hospitalized patients with chronic heart failure (CHF). Methods The data of CHF patients hospitalized in our hospital from January 1998 to December 2008 were investigated. The patients were divided into group A before 2002 and group B afterwards. The general clinical situation, cardiac function classification , Echocardiography indicators, drug use, hospital stay and death, etc. and indicators. Results A total of 620 CHF patients were treated in the recent 10 years, including 178 cases in group A and 442 cases in group B. There was no significant difference in general clinical features, cardiac function classification and echocardiography between the two groups (p> 0.05); B The use of angiotensin converting enzyme inhibitors, β-blockers and spironolactone was significantly higher in group A than in group A, and the use of digoxin and diuretics was slightly lower than group A. The average length of stay in group A was significantly longer than that of group A In group B, the mortality rate during hospitalization was significantly higher than that in group B; there was a statistically significant difference (p <0.005). Conclusion The recommendations of treatment of chronic heart failure significantly improve the level of drug treatment of heart failure in our hospital.